Should marijuana access be expanded? On April 23, 2026, the Trump administration … – Facebook
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMedical MarijuanaMental Health Clinical Summary The Trump administration’s April 2026 policy…
The Biggest Things About Schedule III You Haven’t Thought Of | Cannabis Business Times
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Clinical Summary # Clinical Summary The potential rescheduling of cannabis from Schedule I to…
CBD reduces chronic pain in new randomized controlled trial
✦ New CED Clinical Relevance #82 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDPainResearch Why This Matters Clinicians can now cite higher-quality evidence when counseling patients with…
Trump administration reclassifies cannabis in major shift that could expand scientific research – MSN
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchIndustry Why This Matters Reclassification of cannabis to a lower Schedule could accelerate rigorous…
Amrit Baral: Estimates of Cannabis and Classic Psychedelic Use Among Older U.S. Cancer Survivors
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CancerResearchAgingSafety Why This Matters Clinicians treating older cancer survivors need prevalence data on…
Cannabis Balms for AIMSS: Clinical Trial Evidence
Clinical Takeaway A small clinical trial found that topical cannabis balms were safe and feasible for women with breast cancer experiencing joint and bone pain from aromatase inhibitor medications. The study demonstrates that cannabinoid products can be…
Endocannabinoid System Clinical Research: PTSD Treatment
Clinical Takeaway Trauma-focused treatments for PTSD combined with substance use disorders show comparable effectiveness whether or not patients use cannabis, based on analysis of clinical trial data. Active cannabis use does not significantly impair…
Results from COSMOS trial reveals more than 75% of older adults have used …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AgingResearchSafety Dr. Caplan’s Take “What the COSMOS trial demonstrates is that cannabis use in older…
Marijuana – The Virginian-Pilot
✦ New CED Clinical Relevance #3 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Clinical Perspective I’d be happy to write a clinical perspective paragraph, but I notice…
UNE to launch online program for cannabis certifications – WMUR
✦ New CED Clinical Relevance #5 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearch Clinical Summary The University of New England has launched an online certification program in…